Gregory Steinberg completed his BSc (1998) and PhD (2002) at the University of Guelph in Canada and postdoctoral research in Australia (2006). In 2008 he returned to Canada and McMaster University in Hamilton where a major focus of his research has involved studying how obesity, nutrition and exercise influence health with a primary focus on inflammation and lipid metabolism. An important node of his research involves the AMP activated protein kinase (AMPK) an enzyme that controls whole body energy balance and physiological responses to metabolic stressors such as fasting and exercise. Commonly used medications such as metformin and salicylate also activate AMPK and the Steinberg laboratory has investigated the importance of AMPK and related substrates in mediating their beneficial effects on metabolism.
« Go Back